Q3 2021 13F Holders as of 9/30/2021
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
44.9M
-
Number of holders
-
250
-
Total 13F shares, excl. options
-
49.1M
-
Shares change
-
-103K
-
Total reported value, excl. options
-
$2.75B
-
Value change
-
-$7.82M
-
Put/Call ratio
-
0.34
-
Number of buys
-
112
-
Number of sells
-
-112
-
Price
-
$56.00
Significant Holders of Pacira BioSciences, Inc. - Common Stock, par value $0.001 per share (PCRX) as of Q3 2021
288 filings reported holding PCRX - Pacira BioSciences, Inc. - Common Stock, par value $0.001 per share as of Q3 2021.
Pacira BioSciences, Inc. - Common Stock, par value $0.001 per share (PCRX) has 250 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 49.1M shares
.
Largest 10 shareholders include BlackRock Inc. (6.7M shares), VANGUARD GROUP INC (4.77M shares), MACQUARIE GROUP LTD (3.69M shares), Spyglass Capital Management LLC (2.21M shares), BAILLIE GIFFORD & CO (2.09M shares), RENAISSANCE TECHNOLOGIES LLC (1.97M shares), STATE STREET CORP (1.46M shares), PAULSON & CO. INC. (1.26M shares), LOOMIS SAYLES & CO L P (1.15M shares), and WESTFIELD CAPITAL MANAGEMENT CO LP (1.13M shares).
This table shows the top 250 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.